Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (115 ops.)
Latest filing published 13 May 2025 for Hims & Hers Health, Inc., €683k.
Filing timeline
BuySaleMelissa Baird
Insider track record
Disclosed buys
0
Disclosed sells
115
Signal history
Melissa Baird: trading record in brief
Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., filed 205 reports between January 22, 2021 and May 13, 2025. The record exploded within two years: 12 filings in 2021 and 11 in 2022, then 58 in 2023 and 88 in 2024. The latest is from May 2025: no filing falls in the last twelve months.
The 113 sales are worth EUR 23.5 million, with a median of EUR 90,358; no purchase. The three largest are dated December 10, 2024 (EUR 1,504,473), June 3, 2024 (EUR 1,199,857) and February 12, 2025 (EUR 991,415). The record also holds 72 option exercises, 17 grants and 3 filings of another nature.
The median publication delay is 2 days. At Hims & Hers Health, Inc., 105 of Baird's trades fall within 30 days of a trade by Andrew Dudum, 101 of Soleil Boughton, 99 of Irene Becklund and 99 of Oluyemi Okupe, all in the same direction.
Companies and markets linked to Melissa Baird
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations205 total
13,786 shares@ US$54.982.4% of flowClass A Common StockSEC:0001773751-25-000162:1
6,801 shares@ US$55.861.2% of flowClass A Common StockSEC:0001773751-25-000162:2
7,556 shares@ US$56.801.4% of flowClass A Common StockSEC:0001773751-25-000162:3
5,190 shares@ US$57.870.9% of flowClass A Common StockSEC:0001773751-25-000162:4
33,333 shares@ US$2.431.8% of flowClass A Common StockSEC:0001773751-25-000162:0
22,568 shares@ US$1.750.8% of flowClass A Common StockSEC:0001773751-25-000133:0
10,765 shares@ US$2.430.1% of flowClass A Common StockSEC:0001773751-25-000133:1
27,035 shares@ US$25.65872.1% of flowClass A Common StockSEC:0001773751-25-000133:2
6,298 shares@ US$26.28980.5% of flowClass A Common StockSEC:0001773751-25-000133:3
10,199 shares@ US$25.820.8% of flowClass A Common StockSEC:0001773751-25-000118:1
11,735 shares@ US$26.941.0% of flowClass A Common StockSEC:0001773751-25-000118:2
3,011 shares@ US$28.550.3% of flowClass A Common StockSEC:0001773751-25-000118:3
8,392 shares@ US$29.230.8% of flowClass A Common StockSEC:0001773751-25-000118:4
33,337 shares@ US$1.751.3% of flowClass A Common StockSEC:0001773751-25-000118:0
40,380 shares@ US$5.014.5% of flowClass A Common StockSEC:0001773751-25-000116:0
13,460 shares@ US$5.011.5% of flowClass A Common StockSEC:0001773751-25-000110:0
18,262 shares@ US$33.57092.0% of flowClass A Common StockSEC:0001773751-25-000106:1
18,941 shares@ US$34.50132.1% of flowClass A Common StockSEC:0001773751-25-000106:2
22,558 shares@ US$35.37382.6% of flowClass A Common StockSEC:0001773751-25-000106:3
3,241 shares@ US$36.5990.4% of flowClass A Common StockSEC:0001773751-25-000106:4
4,685 shares@ US$37.35420.6% of flowClass A Common StockSEC:0001773751-25-000106:5
67,687 shares@ US$0.400.6% of flowClass A Common StockSEC:0001773751-25-000106:0
28,779 shares@ US$33.143.1% of flowClass A Common StockSEC:0001773751-25-000095:1
73,150 sharesClass A Common StockSEC:0001773751-25-000095:0
15,641 shares@ US$43.37132.3% of flowClass A Common StockSEC:0001773751-25-000042:1
25 of 205 declarations
